A newly published study points out that NPTX2 is significantly lower in genetic frontotemporal dementia (FTD) and is a novel synaptic marker to predict the progression of FTD disease (van der Ende et al., 2020). The gene discussed is NPTX2; the disease is frontotemporal dementia.